MedTrace Logo

The Effectiveness of Dialectical Behavioral Group Psychotherapy Compared to Supportive Individual Psychotherapy In Patients With Borderline Personality Disorder: A Study on Therapeutic Alliance, Depression, Cognitive Function, Impulsivity, Suicide Risk, BDNF Levels, NFkB Levels, SOD Levels

NCT07449104 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2026-03-06

No results posted yet for this study

Summary

In the context of therapy for Borderline Personality Disorder, our department had conduct a study titled "The Effectiveness of Dialectical Behavioral Group Psychotherapy Compared to Supportive Individual Psychotherapy in Patients with Borderline Personality Disorder: A Study of Therapeutic Alliance, Depression, Cognitive Function, Impulsivity, Suicide Risk, BDNF Levels, NFkB Levels, SOD Levels."

Conditions

  • Borderline Personality Disorder (BPD)

Interventions

BEHAVIORAL

DBT group psychotherapy

13 weeks, one session per week. Each week, one 2-hour dialectical therapy group session for 5 patients in a group.

BEHAVIORAL

Supportive Psychotherapy

13 weeks, one session per week. Each week, one 30-minute session of individual supportive psychotherapy

Sponsors & Collaborators

  • Faculty of Medicine University of Diponegoro, Indonesia

    collaborator UNKNOWN

  • Natalia Dewi Wardani, MD

    lead OTHER

Principal Investigators

  • M.I. Widiastuti MIW Widiastuti, Prof. dr.PAK(K), Sp.S(K), M.Sc · Medical Faculty Diponegoro University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-16
Primary Completion
2022-12-16
Completion
2023-11-05

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07449104 on ClinicalTrials.gov